16 Treffer:
Suchergebnisse 1 bis 10 von 16
1. Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland … an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB…
2. Shield Therapeutics and ewopharma sign Feraccru licence agreement for Switzerland … a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical marketing company headquartered in Schaffhausen, Switzerland, are pleased to announce that they have entered…
3. Ewopharma and Eisai announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib) … SCHAFFHAUSEN, SWITZERLAND and HATFIELD, UK, 26th March, 2020 – Ewopharma, a pharmaceutical marketing company and Eisai Europe Ltd., a leading global research and development-based pharmaceutical company are pleased to…
4. Partner & Marken …Eigenmarken Partner & Marken PARTNER & MARKEN Wir sind Ihr Partner für medizinisches Marketing und Markenführung im Bereich Verbrauchergesundheit – vom Marktzugang bis zur vollständigen Vermarktung. Mit unserer…
5. Otsuka and Ewopharma join the fight against tuberculosis in Romania by launching Deltyba® … TB). Ewopharma and Otsuka’s subsidiary, Otsuka Novel Products GmbH (ONPG), the European Union marketing authorisation holder for Deltyba, have signed a commercial agreement enabling Ewopharma’s Romanian…
6. Führung … ANTONIO MANTARRO Direktor Operations and Customer Relations ANITA MATTLE Direktor Marketing & Consumer Health ALAIN STAUB Geschäftsführer VERWALTUNGSRAT MATTHIAS E.…
7. Ewopharma strengthens its oncology business … Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of 1st…
8. Cookie Policy … us for purposes such as collecting information on user behaviour, demographics, or for personalising marketing or advertising messages to you based on your browsing on the internet. Details about the third…
9. Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS) … in order to launch PROIBS® for the treatment of symptoms related to IBS. This agreement includes all marketing and sales activities of PROIBS® as of April 2022. Simone Thomas, Senior Product Manager at…
10. Datenschutzerklärung … data, e.g. pharmacovigilance personal data may be transferred to our Slovakian affiliate who is the marketing authorisation holder for our own products. It may also be accessed by those who we hire to help us…
Suchergebnisse 1 bis 10 von 16